LY3023414

⇄

cytochrome P450 family 3 subfamily A member 4 ; Homo sapiens







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29636360 A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. 2018 Jul 15 1